Skip to search formSkip to main contentSkip to account menu

BRL 52537

Known as: BRL-52537, BRL52537 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Neuroprotection by the Kappa-Opioid Receptor Agonist, BRL52537, is Mediated via Up-Regulating Phosphorylated Signal Transducer and Activator of Transcription-3 in Cerebral Ischemia/Reperfusion Injury…
The purpose of this study was to investigate whether the kappa-opioid receptor (KOR) agonist, BRL52537, has a neuroprotective… 
2008
2008
The Neuroprotection of Kappa Opioid Receptor Agonist BRL52537 is Partly Through Enhancing Endogenous GABA Function
Highly Cited
2004
Highly Cited
2004
Effect of Exogenous Kappa-Opioid Receptor Activation in Rat Model of Myocardial Infarction
The involvement of opioid receptor activation during ischemia-reperfusion is somewhat controversial. While it is generally… 
2003
2003
Kappa-Opioid Receptor Selectivity for Ischemic Neuroprotection with BRL 52537 in Rats
&kgr;-Opioid receptors (KOR) have been implicated in neuroprotection from ischemic neuronal injury, but less work has been… 
2003
2003
Nitric Oxide Production In Vivo in Rats-Opioid Receptor Agonist BRL 52537 Attenuates Ischemia-Evoked κ Neuroprotective
Toru Goyagi, Thomas J.K. Toung, Jeffrey R. Kirsch, Richard J. Traystman, Raymond C. Nitric Oxide Production In Vivo in Rats… 
2002
2002
Inhibition of cAMP accumulation by kappa-receptor activation in isolated iris-ciliary bodies: role of phosphodiesterase and protein kinase C.
The present study was designed to examine the roles of protein kinase C (PKC) and phosphodiesterase (PDE) in modulating the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)